Lin, Andrew A.
Shen, Hanfei
Spychalski, Griffin
Carpenter, Erica L.
Issadore, David
Funding for this research was provided by:
National Institute of Mental Health (R21MH118170)
National Cancer Institute (R21CA236653)
Paul G. Allen Frontiers Group (12347)
U.S. Department of Defense (W81XWH1920002)
National Institutes of Health (RM1HG010023)
Article History
Received: 9 May 2023
Accepted: 30 July 2023
First Online: 16 August 2023
Competing interests
: For our conflicts of interest to disclose, Dr. David Issadore is a founder of Chip Diagnostics and holds equity in the company. The other authors listed do not have competing interests.